BM aspirate

DIAGNOSTIC_TEST2 trials

Sponsors

National Cancer Institute (NCI), Sohag University

Conditions

Acute LeukemiaHodgkin's LymphomaMultiple MyelomaMyelodysplastic SyndromesNon-Hodgkin's Lymphoma

Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

CompletedNCT02356159

National Cancer Institute (NCI)Acute Leukemia, Hodgkin's Lymphoma, Multiple Myeloma +2

Start: 2015-09-24End: 2025-03-25Updated: 2025-09-30

Unknown Phase

Study of miRNA-155 in Acute Leukemia

Sohag UniversityAcute Leukemia

Start: 2023-04-30End: 2024-04-30Target: 50Updated: 2023-04-12

Related Papers

Impact of fludarabine exposure on overall survival in patients receiving fludarabine/cyclophosphamide reduced intensity conditioning hematopoietic cell transplantation for hematologic malignancies

Blood2025-11-03

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

Blood2025-05-071 citations

Preconditioning Single High-Dose Palifermin Alters the Posttransplant Inflammatory Cytokine Profile

Blood2023-11-02

A Phase 1 Single Dose Escalation Study of Palifermin Administered Pre-Transplant Conditioning in Subjects Undergoing Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Blood2020-11-052 citations